Document is current
Any future updates will be listed below
-
Authors
Tank, Amarjeet https://orcid.org/0000-0002-9523-4365
Johnston, S Claiborne
Jain, Ritika
Amarenco, Pierre
Mellström, Carl https://orcid.org/0000-0002-1088-3770
Rikner, Klas
Denison, Hans
Ladenvall, Per
Knutsson, Mikael
Himmelmann, Anders
Evans, Scott R
James, Stefan
Molina, Carlos A
Wang, Yongjun
Ouwens, Mario
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03354429 at ClinicalTrials.govnct01994720 at ClinicalTrials.govDocuments that mention this clinical trial
Carotid Stenosis and Recurrent Ischemic Stroke
https://doi.org/10.1161/strokeaha.121.034089
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
https://doi.org/10.1161/strokeaha.121.035555
Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
https://doi.org/10.1136/svn-2018-000168
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
https://doi.org/10.1136/bmjno-2023-000478
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
https://doi.org/10.1161/strokeaha.120.032239
nct03354429 at ClinicalTrials.govDocuments that mention this clinical trial
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
https://doi.org/10.1136/heartjnl-2015-307858
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
https://doi.org/10.1136/bmjno-2023-000478
Documents that mention this clinical trial
Carotid Stenosis and Recurrent Ischemic Stroke
https://doi.org/10.1161/strokeaha.121.034089
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
https://doi.org/10.1161/strokeaha.121.035555
Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
https://doi.org/10.1136/svn-2018-000168
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
https://doi.org/10.1136/bmjno-2023-000478
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
https://doi.org/10.1161/strokeaha.120.032239
-
Funding
Funding for this research was provided by:
AstraZeneca (N/A)
- License Information
